2025 HCPCS Code J2281
Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg
TAGS: equivalent moxifloxacin therapeutically| Short Description | Inj moxifloxacin (fres kabi) |
| HCPCS Action Code | C - Change in long description of procedure or modifier code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | January 01, 2023 |
| HCPCS Action Effective Date | July 01, 2024 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J7042 - 5% dextrose/normal saline
- J7050 - Normal saline solution infus
- J7060 - 5% dextrose/water
- J7070 - D5w infusion
- J7100 - Dextran 40 infusion
- J7110 - Dextran 75 infusion
- J7120 - Ringers lactate infusion
- J7121 - 5% dextrose in lac ringers
- J7131 - Hypertonic saline sol
- J7165 - Inj, human-lans, per i.u
- J7168 - Prothrombin complex kcentra
- J7169 - Inj andexxa, 10 mg
- J7170 - Inj., emicizumab-kxwh 0.5 mg
- J7171 - Inj, adzynma, 10 iu
- J7175 - Inj, factor x, (human), 1iu
- J7177 - Inj., fibryga, 1 mg
- J7178 - Inj human fibrinogen con nos
- J7179 - Vonvendi inj 1 iu vwf:rco
- J7180 - Factor xiii anti-hem factor
- J7181 - Factor xiii recomb a-subunit